Cambridge Investment Research Advisors, Inc.
Position in NKTR — Nektar Therapeutics
CIK 1419186
FAIRFIELD, IA
Position in NKTR
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,922,344
-$110,813 QoQ
Shares Held
56,186
+0.2% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#74
of 239 holders
Holding Since
Mar 2020
21 quarters on record
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. NKTR ranks #3 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
This page
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in NKTR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,922,344 | 56,186 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $4,033,157 | 56,055 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,270,985 | 53,713 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,653,588 | 46,636 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $312,198 | 12,082 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $92,466 | 135,980 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $117,882 | 126,755 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $171,834 | 132,180 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $152,371 | 122,880 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $117,188 | 126,009 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $72,749 | 129,909 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $80,811 | 134,685 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $79,435 | 136,957 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $96,009 | 137,157 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $298,844 | 132,232 | Shares | Sole | 2023-02-08 | |
| 2021-06-30 | $176,662 | 10,295 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $206,400 | 10,320 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $182,920 | 10,760 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $196,757 | 11,860 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $274,515 | 11,853 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $227,498 | 12,745 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||